• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday

    8/8/22 3:05:40 AM ET
    $AAMC
    $ACMR
    $ACOR
    $AERI
    Real Estate
    Finance
    Industrial Machinery/Components
    Technology
    Get the next $AAMC alert in real time by email

    Gainers

    • Cooper-Standard Holdings Inc. (NYSE:CPS) jumped 69.6% to close at $8.53 on Friday following better-than-expected Q2 results.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) surged 64.4% to settle at $3.60 amid volatility in several recent small-cap IPOs.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) shares gained 63.6% to close at $0.54. The U.S. Food and Drug Administration (FDA) announced clearance to Marker Therapeutics’ Investigational New Drug (IND) application for MT-601 for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma.
    • Athenex, Inc. (NASDAQ:ATNX) jumped 51.6% to close at $0.9550 as India's Intas Pharmaceuticals and Dr Reddy's Laboratories Ltd are reportedly in talks to acquire Athenex.
    • Bonso Electronics International Inc. (NASDAQ:BNSO) gained 46.2% to settle at $4.78.
    • Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPA) rose 45.8% to settle at $0.91.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares jumped 45.8% to close at $3.63.
    • Heritage Insurance Holdings, Inc. (NASDAQ:HRTG) jumped 44% to close at $3.50 following Q2 earnings.
    • AlerisLife Inc. (NASDAQ:ALR) gained 43.7% to settle at $1.71. AlerisLife recently posted a Q2 loss of $0.28 per share.
    • Carvana Co. (NYSE:CVNA) jumped 40.1% to close at $46.98 after the company reported Q2 earnings results.
    • Progyny, Inc. (NASDAQ:PGNY) jumped 38.2% to close at $41.15 after the company reported better-than-expected Q2 results.
    • Boqii Holding Limited (NYSE:BQ) gained 34.9% to settle at $2.71.
    • Global Blood Therapeutics, Inc. (NASDAQ:GBT) rose 33% to settle at $63.84 following reports suggesting Pfizer is in talks to acquire the company.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) gained 32.7% to settle at $8.16.
    • Sientra, Inc. (NASDAQ:SIEN) rose 31.1% to settle at $1.39.
    • Sensus Healthcare, Inc. (NASDAQ:SRTS) surged 30.7% to close at $14.55 following strong quarterly results.
    • GH Research PLC (NASDAQ:GHRS) gained 29.8% to close at $15.80.
    • Elite Education Group International Limited (NASDAQ:EEIQ) gained 29.2% to close at $1.99.
    • Q&K International Group Limited (NASDAQ:QK) gained 29.2% to close at $3.05 amid volatility in small-cap Chinese stocks.
    • Vroom, Inc. (NASDAQ:VRM) gained 28.9% to close at $2.32.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) climbed 28.7% to close at $22.76 after dipping 34% on Thursday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
    • Incannex Healthcare Limited (NASDAQ:IXHL) gained 28.7% to close at $4.89.
    • Four Seasons Education (Cayman) Inc. (NYSE:FEDU) rose 28.7% to settle at $16.50.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 27.4% to close at $5.02.
    • Helbiz, Inc. (NASDAQ:HLBZ) jumped 27.2% to settle at $0.7501.
    • Cloudflare, Inc. (NYSE:NET) shares gained 27.1% to close at $74.24 after the company reported better-than-expected Q2 sales and raised FY22 sales guidance.
    • Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) surged 26.6% to settle at $6.10.
    • ATIF Holdings Limited (NASDAQ:ATIF) jumped 26.1% to settle at $2.3831.
    • Selecta Biosciences, Inc. (NASDAQ:SELB) climbed 25.5% to close at $2.36. Selecta Biosciences reported Q2 sales results up year over year.
    • Altisource Asset Management Corporation (NASDAQ:AAMC) gained 25.3% to close at $21.86.
    • Unico American Corporation (NASDAQ:UNAM) jumped 25% to close at $2.25.
    • Aemetis, Inc. (NASDAQ:AMTX) jumped 24.8% to close at $10.18. The company yesterday reported Q2 results.
    • Highway Holdings Limited (NASDAQ:HIHO) gained 24.4% to close at $2.24.
    • G1 Therapeutics, Inc. (NASDAQ:GTHX) rose 24% to settle at $13.01. The company recently posted upbeat Q2 results.
    • Atlas Corp. (NYSE:ATCO) gained 22.9% to close at $14.22 after the company said it received a non-binding proposal from Poseidon Acquisition Corp. to acquire all outstanding common shares of Atlas for $14.45 per share.
    • ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) jumped 22.8% to close at $4.63.
    • Quaker Chemical Corporation (NYSE:KWR) gained 22.2% to close at $186.96 following better-than-expected Q2 results.
    • bluebird bio, Inc. (NASDAQ:BLUE) jumped 22.1% to settle at $5.59 after Barclays upgraded the stock from Underweight to Equal-Weight and raised its price target from $3 to $5.
    • Beyond Meat, Inc. (NASDAQ:BYND) rose 21.9% to close at $38.26 following Q2 results.
    • Opendoor Technologies Inc. (NASDAQ:OPEN) rose 21.7% to close at $5.72 following Q2 results.
    • Scholar Rock Holding Corporation (NASDAQ:SRRK) jumped 21.3% to settle at $8.50.
    • Assure Holdings Corp. (NASDAQ:IONM) shares gained 21% to close at $2.54 after jumping around 104% on Thursday.
    • Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) gained 20.9% to close at $8.91 after reporting upbeat quarterly results.
    • Clean Energy Fuels Corp. (NASDAQ:CLNE) gained 19.8% to close at $7.57 following Q2 results.
    • Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) rose 19.2% to close at $15.69 after the company announced a $250 million investment from Warburg Pincus in Calumet's Montana Renewables LLC subsidiary. The company also reported better-than-expected Q2 sales.
    • iRobot Corporation (NASDAQ:IRBT) climbed 19.1% to close at $59.54 after Amazon announced it will acquire the company for $61 per share.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) climbed 18.9% to settle at $22.18. The company reported Q2 earnings results and announced the declaration of a special dividend of one AMC Preferred Equity unit for each share of AMC Class A common stock.
    • Tripadvisor, Inc. (NASDAQ:TRIP) gained 18.9% to close at $23.86 after the company reported better-than-expected Q2 EPS and sales results.
    • Yelp Inc. (NYSE:YELP) gained 18.4% to close at $38.26 after the company reported better-than-expected Q2 EPS and sales results and issued FY2022 sales guidance above estimates.
    • HyreCar Inc. (NASDAQ:HYRE) rose 18.3% to settle at $0.84.
    • Staffing 360 Solutions, Inc. (NASDAQ:STAF) shares gained 18.2% to close at $4.35 after gaining around 15% on Thursday.
    • Pop Culture Group Co., Ltd (NASDAQ:CPOP) gained 17% to close at $1.72.
    • fuboTV Inc. (NYSE:FUBO) gained 16.8% to close at $3.47 after the company posted a double-digit surge in quarterly revenue.
    • Lyft, Inc. (NASDAQ:LYFT) gained 16.6% to close at $20.28 as the company reported upbeat results for its second quarter. Lyft saw active riders of 19.9 million last quarter, up 15.9% year-over-year. Revenue per active rider was $49.89 in the second quarter, up 11.8% year-over-year.
    • Penumbra, Inc. (NYSE:PEN) jumped 16.6% to close at $166.83 after the company reported better-than-expected Q2 EPS and sales results.
    • Atlassian Corporation Plc (NASDAQ:TEAM) gained 16.6% to close at $268.59 after the company reported better-than-expected Q4 EPS and sales results and issued Q1 sales guidance above estimates.
    • Talos Energy Inc. (NYSE:TALO) gained 14.3% to close at $18.35 after the company reported better-than-expected Q2 adjusted EPS and sales results.
    • Floor & Decor Holdings, Inc. (NYSE:FND) gained 13.5% to close at $92.92 following upbeat quarterly earnings.
    • Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) jumped 13.5% to close at $33.47.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) rose 13% to close at $1.83 after the company announced an expanded collaboration with GroveToken LLC to include a 12-month-long global campaign to help raise awareness for their GreenKeeper and GreenOasis technologies.
    • Paylocity Holding Corporation (NASDAQ:PCTY) rose 12.7% to close at $255.26 following Q4 results.
    • WeTrade Group, Inc. (NASDAQ:WETG) rose 12.7% to close at $20.62 after the company announced a strategic partnership with Jiqing Bio Company to exclusively sell monkeypox test kits and antigen tests.
    • Twist Bioscience Corporation (NASDAQ:TWST) gained 12.7% to close at $52.77 after the company reported better-than-expected Q3 EPS and sales results and raised FY22 revenue guidance above analyst estimates.
    • Tattooed Chef, Inc. (NASDAQ:TTCF) rose 12.5% to close at $7.64.
    • Fox Factory Holding Corp. (NASDAQ:FOXF) gained 12.3% to close at $106.05 after the company reported better-than-expected Q2 EPS and sales results and issued Q3 and FY22 sales guidance above estimates. Following earnings, Stifel upgraded the stock from Hold to Buy and raised its price target from $88 to $115.
    • Peloton Interactive, Inc. (NASDAQ:PTON) rose 12.3% to close at $11.79. Peloton Interactive is expected to release its Q4 results before the U.S. stock market opens on Thursday, August 25, 2022.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) gained 12% to close at $2.70.
    • Amicus Therapeutics, Inc. (NASDAQ:FOLD) gained 11.3% to settle at $12.18. Amicus Therapeutics recently reported Q2 loss of $0.21 per share.
    • Mirati Therapeutics, Inc. (NASDAQ:MRTX) climbed 11.1% to close at $86.56. The company recently posted upbeat Q2 results.
    • New Relic, Inc. (NYSE:NEWR) rose 10.1% to close at $67.53 after the company reported better-than-expected Q1 EPS and sales results.
    • DraftKings Inc. (NASDAQ:DKNG) rose 9.8% to close at $17.96 after the company reported better-than-expected Q2 sales results and raised FY22 sales guidance. The company also reported monthly unique players increased 30% year over year.
    • AMN Healthcare Services, Inc. (NYSE:AMN) gained 8.9% to close at $117.83 following upbeat quarterly results.
    • AMTD IDEA Group (NYSE:AMTD) rose 8.8% to close at $4.68 after dipping over 31% on Thursday.
    • Reinsurance Group of America, Incorporated (NYSE:RGA) rose 8.7% to close at $123.42 following upbeat quarterly earnings.
    • TMC the metals company Inc. (NASDAQ:TMC) shares gained 8% to close at $0.9410.
    • Cavco Industries, Inc. (NASDAQ:CVCO) gained 7.3% to close at $274.30 after the company reported better-than-expected Q1 EPS and sales results. Following earnings, Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $315 to $385.
    • Brighthouse Financial, Inc. (NASDAQ:BHF) gained 6.2% to settle at $45.13 on strong quarterly results.
    • ACM Research, Inc. (NASDAQ:ACMR) rose 6.2% to close at $19.13 after the company reported Q2 results.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) shares rose 5.1% to close at $0.9434 after reporting strong Q2 results.

     

    Losers

    • Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares dipped 62.4% to close at $5.29 on Friday after the company priced a $16.8 million public offering.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) dropped 53.1% to close at $0.4782 after the company announced pricing of $18 million public offering.
    • Hyzon Motors Inc. (NASDAQ:HYZN) fell 38.1% to close at $2.78 after the company late Thursday disclosed an investigation into internal controls and revenue recognition timing. JP Morgan downgraded the stock to Underweight on Friday.
    • Health Catalyst, Inc. (NASDAQ:HCAT) dipped 37.9% to settle at $11.35 after the company issued weak sales forecast and announced a $40 million share repurchase program. JP Morgan and Stifel also downgraded the stock.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) dropped 25.8% to close at $3.74.
    • Exagen Inc. (NASDAQ:XGN) fell 23.6% to settle at $6.34 after reporting Q2 results. Exagen initiated study to predict Rheumatoid Arthritis Drug Response (RADR) in patients with RA.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) dipped 22.3% to close at $2.12.
    • Regional Health Properties, Inc. (NYSE:RHE) declined 22.1% to close at $3.73.
    • Valhi, Inc. (NYSE:VHI) dropped 21% to close at $40.97 after the company reported Q2 earnings results.
    • Histogen Inc. (NASDAQ:HSTO) fell 20.8% to close at $2.47.
    • Profound Medical Corp. (NASDAQ:PROF) fell 20.7% to close at $7.38 following Q2 results.
    • CN Energy Group. Inc. (NASDAQ:CNEY) dropped 19.9% to settle at $2.17.
    • Intrusion Inc. (NASDAQ:INTZ) fell 19.1% to close at $3.94 following Q2 results.
    • UserTesting, Inc. (NYSE:USER) dropped 18.4% to settle at $4.87 after Raymond James maintained a Strong Buy rating on the stock but lowered its price target from $14 to $9.
    • Funko, Inc. (NASDAQ:FNKO) dipped 18.3% to close at $21.81 following Q2 results.
    • Astra Space, Inc. (NASDAQ:ASTR) fell 17.7% to close at $1.30 following Q2 results.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) fell 17.5% to close at $6.76 after the company reported mixed financial results.
    • MediaAlpha, Inc. (NYSE:MAX) fell 17.4% to close at $10.01 following weak quarterly results.
    • Definitive Healthcare Corp. (NASDAQ:DH) fell 16.5% to close at $24.50 after the company issued guidance below consensus estimates.
    • Warner Bros. Discovery, Inc. (NASDAQ:WBD) fell 16.4% to close at $14.59 after the company posted a loss for the second quarter.
    • WW International, Inc. (NASDAQ:WW) fell 15.8% to close at $6.18 following Q2 results.
    • Lordstown Motors Corp. (NASDAQ:RIDE) dipped 15.4% to settle at $2.52 as the company recently reported Q2 earnings.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 15.2% to close at $0.4450 after posting a wider Q2 loss.
    • Winc, Inc. (NYSE:WBEV) dropped 14.4% to settle at $1.66.
    • Tutor Perini Corporation (NYSE:TPC) dropped 14.2% to close at $7.76 after the company reported worse-than-expected Q2 EPS and sales results.
    • Greenlane Holdings, Inc (NASDAQ:GNLN) fell 14.2% to close at $0.1582. Greenlane reported board's Approval of 1-for-20 reverse stock split ratio, effective August 9, 2022.
    • Twilio Inc. (NYSE:TWLO) fell 13.5% to close at $84.92 after the company issued Q3 sales guidance below estimates.
    • Cinemark Holdings, Inc. (NYSE:CNK) dropped 13.4% to settle at $16.75 after the company reported Q2 earnings results.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) fell 13.1% to close at $3.13. Cognition Therapeutics shares jumped 65% on Thursday after the company presented a proteomic analysis of clinical biomarker data from the SPARC study of CT1812 in mild-to-moderate Alzheimer's disease at the Alzheimer's Association International Conference.
    • NN, Inc. (NASDAQ:NNBR) fell 12.1% to close at $2.46 following downbeat quarterly results.
    • Green Dot Corporation (NASDAQ:GDOT) fell 13.4% to close at $24.52 following weak quarterly sales.
    • Grand Canyon Education, Inc. (NASDAQ:LOPE) dropped 10.7% to settle at $84.67 after the company reported worse-than-expected Q2 sales results and issued FY22 adjusted EPS guidance below analyst estimates.
    • AMTD Digital Inc. (NYSE:HKD) fell 9.9% to settle at $721.23 on possible profit taking after the stock surged over the last few trading days..
    • Mueller Water Products, Inc. (NYSE:MWA) fell 9.8% to close at $11.83 after the company reported worse-than-expected Q3 EPS results.
    • Fluor Corporation (NYSE:FLR) dropped 9.1% to close at $23.08 after the company reported Q2 EPS results were lower year-over-year alongside worse-than-expected Q2 sales results.
    • NortonLifeLock Inc. (NASDAQ:NLOK) fell 9% to close at $24.21 after the company reported worse-than-expected Q1 sales results.
    • WPP plc (NYSE:WPP) fell 8.4% to settle at $49.43 as the company reported its 2022 Interim Results.
    • Teradata Corporation (NYSE:TDC) tumbled 8.1% to close at $35.71 after the company reported worse-than-expected Q2 sales results.
    • B&G Foods, Inc. (NYSE:BGS) dipped 7.5% to close at $23.43 following weak quarterly results.
    • Doximity, Inc. (NYSE:DOCS) fell 7.4% to close at $37.31 as the company lowered its FY23 sales guidance.
    • DURECT Corporation (NASDAQ:DRRX) fell 5% to close at $0.5987 after the company posted a wider quarterly loss.
    Get the next $AAMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAMC
    $ACMR
    $ACOR
    $AERI

    CompanyDatePrice TargetRatingAnalyst
    Warner Bros. Discovery Inc.
    $WBD
    2/17/2026$31.00Buy → Neutral
    Rothschild & Co Redburn
    DraftKings Inc.
    $DKNG
    2/17/2026$52.00 → $35.00Buy
    Needham
    Cloudflare Inc.
    $NET
    2/13/2026$215.00Hold → Buy
    DZ Bank
    Cloudflare Inc.
    $NET
    2/11/2026$260.00Neutral → Outperform
    Robert W. Baird
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Doximity Inc.
    $DOCS
    2/9/2026$34.00Hold → Buy
    Canaccord Genuity
    DraftKings Inc.
    $DKNG
    2/6/2026$41.00 → $32.00Outperform
    Bernstein
    Doximity Inc.
    $DOCS
    2/6/2026$40.00Underweight → Neutral
    Analyst
    More analyst ratings

    $AAMC
    $ACMR
    $ACOR
    $AERI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Liu Gene sold $5,370 worth of shares (66 units at $81.36), decreasing direct ownership by 0.11% to 60,354 units (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    2/20/26 6:01:16 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Chief Revenue Officer Duffy Brian sold $99,410 worth of shares (1,222 units at $81.35), decreasing direct ownership by 0.97% to 124,332 units (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    2/20/26 6:00:45 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Chief Technology Officer Rajan Rajeev Bashyam sold $249,907 worth of shares (3,072 units at $81.35), decreasing direct ownership by 1% to 212,916 units (SEC Form 4)

    4 - Atlassian Corp (0001650372) (Issuer)

    2/20/26 6:00:29 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    $AAMC
    $ACMR
    $ACOR
    $AERI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Risher John David bought $100,179 worth of shares (7,490 units at $13.38), increasing direct ownership by 0.07% to 11,481,792 units (SEC Form 4)

    4 - Lyft, Inc. (0001759509) (Issuer)

    2/18/26 4:10:21 PM ET
    $LYFT
    Real Estate

    Director Sloan Harry bought $2,185,000 worth of shares (100,000 units at $21.85), increasing direct ownership by 40% to 350,219 units (SEC Form 4)

    4 - DraftKings Inc. (0001883685) (Issuer)

    2/18/26 9:16:04 AM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Director Greenblatt David A. bought $234,725 worth of shares (500 units at $469.45), increasing direct ownership by 3% to 16,076 units (SEC Form 4)

    4 - CAVCO INDUSTRIES, INC. (0000278166) (Issuer)

    2/5/26 9:50:43 AM ET
    $CVCO
    Homebuilding
    Consumer Discretionary

    $AAMC
    $ACMR
    $ACOR
    $AERI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

    2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed Acquisition by BioMarin Expected to Close in Q2 2026, Subject to Closing Conditions PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD), a leading, global biotechnology company with a clear and compelling mission to develop and deliver transformative medicines for people living with rare diseases, today announced financial results for the full year ended December 31, 2025. Full-Year 2025 Financial Highlights: Total revenues for the full year 2025 were $634.2 million, reflecting strong operational growth measured at constant exchange rates

    2/20/26 4:01:00 PM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cooper Standard Announces Pricing of $1.1 Billion of Senior Secured First Lien Notes

    NORTHVILLE, Mich., Feb. 20, 2026 /PRNewswire/ -- Cooper-Standard Holdings Inc. (NYSE:CPS) ("Cooper Standard," "Company" or "we") today announced the pricing of the private offering by its wholly-owned subsidiary, Cooper-Standard Automotive Inc. (the "Issuer"), of $1,100.0 million in aggregate principal amount of 9.250% Senior Secured First Lien Notes due 2031 (the "Notes"). The Notes will be the senior secured obligations of, and will be guaranteed on a senior secured basis by, CS Intermediate HoldCo 1 LLC and certain of the Issuer's domestic subsidiaries that guarantee certain other indebtedness. The Notes will also be guaranteed on a senior unsecured basis by Cooper-Standard Latin America

    2/20/26 3:16:00 PM ET
    $CPS
    Auto Parts:O.E.M.
    Consumer Discretionary

    UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results

    Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22 DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q4 2025% ChangeQ4 2024Full Year2025% ChangeFull Year2024Revenue$748.22%$2,730.4(8%)Gross profit$195.1(11%)$774.1(16%)Net income (loss)($7.7)nm($95.7)nmDiluted earnings (loss) per share($0.20)nm($2.48)nmAdjusted diluted EPS*$0.22(70%)$1.36(59%)Adjusted EBITDA*$

    2/19/26 8:13:45 PM ET
    $AMN
    Professional Services
    Consumer Discretionary

    $AAMC
    $ACMR
    $ACOR
    $AERI
    SEC Filings

    View All

    Solana Company filed SEC Form 8-K: Other Events

    8-K - Solana Co (0001610853) (Filer)

    2/20/26 5:07:27 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 144 filed by Cloudflare Inc.

    144 - Cloudflare, Inc. (0001477333) (Subject)

    2/20/26 4:28:54 PM ET
    $NET
    Computer Software: Prepackaged Software
    Technology

    Cooper-Standard Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Cooper-Standard Holdings Inc. (0001320461) (Filer)

    2/20/26 4:05:27 PM ET
    $CPS
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AAMC
    $ACMR
    $ACOR
    $AERI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Warner Bros. Discovery downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Warner Bros. Discovery from Buy to Neutral and set a new price target of $31.00

    2/17/26 8:13:55 AM ET
    $WBD
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Needham reiterated coverage on DraftKings with a new price target

    Needham reiterated coverage of DraftKings with a rating of Buy and set a new price target of $35.00 from $52.00 previously

    2/17/26 7:06:48 AM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Cloudflare upgraded by DZ Bank with a new price target

    DZ Bank upgraded Cloudflare from Hold to Buy and set a new price target of $215.00

    2/13/26 8:21:41 AM ET
    $NET
    Computer Software: Prepackaged Software
    Technology

    $AAMC
    $ACMR
    $ACOR
    $AERI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for KRAZATI issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/14/22 7:40:10 AM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/12/22 6:09:02 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ACMR
    $ACOR
    $AERI
    Financials

    Live finance-specific insights

    View All

    Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

    2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed Acquisition by BioMarin Expected to Close in Q2 2026, Subject to Closing Conditions PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD), a leading, global biotechnology company with a clear and compelling mission to develop and deliver transformative medicines for people living with rare diseases, today announced financial results for the full year ended December 31, 2025. Full-Year 2025 Financial Highlights: Total revenues for the full year 2025 were $634.2 million, reflecting strong operational growth measured at constant exchange rates

    2/20/26 4:01:00 PM ET
    $FOLD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results

    Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22 DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q4 2025% ChangeQ4 2024Full Year2025% ChangeFull Year2024Revenue$748.22%$2,730.4(8%)Gross profit$195.1(11%)$774.1(16%)Net income (loss)($7.7)nm($95.7)nmDiluted earnings (loss) per share($0.20)nm($2.48)nmAdjusted diluted EPS*$0.22(70%)$1.36(59%)Adjusted EBITDA*$

    2/19/26 8:13:45 PM ET
    $AMN
    Professional Services
    Consumer Discretionary

    AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results

    Quarterly revenue of $748 million; GAAP loss of ($0.20)/share and adjusted EPS of $0.22 DALLAS, Feb. 19, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its fourth quarter and full year 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts.  Q4 2025% ChangeQ4 2024Full Year2025% ChangeFull Year2024Revenue$748.22%$2,730.4(8%)Gross profit$195.1(11%)$774.1(16%)Net income (loss)($7.7)nm($95.7)nmDiluted earnings (loss) per share($0.20)nm($2.48)nmAdjusted diluted EPS*$0.22(70%)$1.36(59%)Adjusted EBITDA*$

    2/19/26 4:15:00 PM ET
    $AMN
    Professional Services
    Consumer Discretionary

    $AAMC
    $ACMR
    $ACOR
    $AERI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/17/24 4:18:46 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $AAMC
    $ACMR
    $ACOR
    $AERI
    Leadership Updates

    Live Leadership Updates

    View All

    Atlassian Appoints James Chuong as Chief Financial Officer

    Atlassian Corporation (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced the appointment of James Chuong as Chief Financial Officer (CFO), effective March 30, 2026. As CFO, James will oversee Atlassian's Finance and Legal teams, bringing more than 20 years of finance leadership experience across the technology and investment banking sectors. Most recently, James served as Chief Financial Officer at LinkedIn, where he led the company's financial operations and helped guide it to more than 1 billion members and $18 billion in revenue. During his 13 years at LinkedIn, he held several finance leadership roles, leading global teams responsible

    2/18/26 5:15:00 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Health Catalyst Appoints Ben Albert as Chief Executive Officer

    Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in HealthcareHealth Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ -- Health Catalyst, Inc. (NASDAQ:HCAT) ("Health Catalyst" or the "Company"), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert, the Company's President and Chief Operating Officer (COO), was appointed to serve as Chief Executive Officer (CEO) and as a member of Health Catalyst's Board of Directors ( "Board"), effective February 12, 2026.

    2/18/26 8:55:00 AM ET
    $HCAT
    Computer Software: Programming Data Processing
    Technology

    Greenlane Appoints Jason Hitchcock as Chief Executive Officer to Advance Digital Asset Treasury Strategy

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN) today announced the appointment of Jason Hitchcock as its Chief Executive Officer, effective immediately. Mr. Hitchcock is a technology executive with over 15 years of experience building and scaling revenue engines across SaaS, blockchain infrastructure, and decentralized finance. He joins Greenlane as the Company continues to execute its Berachain-focused Digital Asset Treasury ("DAT") strategy, combining disciplined capital allocation with active ecosystem participation through validator operations, staking, and liquidity provisioning. Technology Leadership and Ent

    2/18/26 8:00:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary